Literature DB >> 28458878

Rendering a ruptured arteriovenous malformation more susceptible to spontaneous obliteration as a possible treatment strategy for cerebral AVM.

Szu-Kai Hsu1,2, Chih-Ju Chang1,3, I-Chang Su1,3.   

Abstract

Spontaneous regression of cerebral arteriovenous malformation (AVM) is a rare phenomenon, but its occurrence is an important consideration in treatment planning. A 58-year-old male was found to have a high-flow AVM of Spetzler-Martin Grade III. Before his scheduled treatment, the AVM ruptured with a large parenchymal hemorrhage. Following emergency decompressive surgery, a targeted embolization procedure was performed to obliterate the ruptured weak point and to reduce the shunting flow. The residual AVM became a malformation harboring angio-architectural factors favoring spontaneous obliteration. Together with other favorable clinical factors, including prior parenchymal hemorrhage and neurosurgical intervention, the residual AVM spontaneously regressed in 2 months. This case highlighted a possible treatment strategy in that, for a ruptured AVM in which definite treatment is not possible, an alternative is to treat the AVM into a situation in which as many favorable factors as possible for spontaneous AVM regression are present.

Entities:  

Year:  2017        PMID: 28458878      PMCID: PMC5400483          DOI: 10.1093/jscr/rjx073

Source DB:  PubMed          Journal:  J Surg Case Rep        ISSN: 2042-8812


U

Cerebral arteriovenous malformation (AVM) is a heterogeneous cerebrovascular disease in which the clinical manifestation varies widely. While most AVMs require treatment when they become symptomatic or even rupture [1], other AVMs might regress spontaneously without any treatment or following partial treatment [2]. The phenomenon of spontaneous AVM regression is multifactorial, but the relationships between various factors remain complex and controversial. Whatever the cause, the importance of this rare phenomenon cannot be over-emphasized, because its occurrence is a consideration in treatment planning for cerebral AVM. Herein, we report a case in which a ruptured cerebral AVM regressed after the patient received emergency decompressive surgery and targeted embolization of the AVM. We analyzed possible contributing factors to this phenomenon, and proposed our experience in this case as the basis for an alternative treatment strategy for a ruptured AVM when definite treatment is not possible.

CASE REPORT

A 58-year-old male presented to the hospital with a right focal seizure involving face and upper arm, and the computed tomography (CT) angiography revealed a high-flow AVM involving left temporo-occipital lobes (Fig. 1A). The AVM was fed by multiple arterial feeders coming from branches of the middle cerebral artery and posterior cerebral artery, and it drained into a single large draining vein (vein of Labbe) via three smaller cortical veins, one of which was dilated into a venous aneurysm (Fig. 1 B and C). Before his scheduled treatment, the patient suddenly lost consciousness, with a Glasgow Coma Scale (GCS) of 5. Emergency CT scan revealed a large parenchymal hemorrhage (Fig. 1D). Because of the life-threatening situation, we performed a decompressive craniectomy and hematoma evacuation immediately in order to relieve the mass effect. We then performed targeted embolization of the AVM to reduce its hemorrhagic risk. We advanced a microcatheter trans-venously into the ruptured venous aneurysm, and deployed two detachable coils within the aneurysm without obstructing the venous outflow (Fig. 1 E and F). We also trans-arterially embolized several arterial feeders by using 20% n-butyl cyanoacrylate glue. Our aim was to secure the ruptured venous aneurysm as well as to reduce the shunting flow. On the final angiogram, the size and flow of the residual AVM significantly reduced (Fig. 1 G). As the patient remained unconscious in the following weeks, definite AVM treatment, either by neurosurgery or radiosurgery, was not performed. Three months later, the patient recovered to a GCS of 11 and Glasgow Outcome Score of 3. Follow-up CT showed complete resolution of the brain edema (Fig. 1 H), and the angiography demonstrated complete angiographic obliteration of the residual AVM (Fig. 1 I). Additional definite treatment was, therefore, not necessary.
Figure 1:

(A) CT angiography (coronal view) revealed a 4-cm AVM at the left temporo-occipital region. (B and C) Lateral projection of early (B) and frontal projection of late (C) arterial phase of left internal carotid angiograms demonstrated a high-flow AVM and a co-existing venous aneurysm on the draining vein (arrow), which ruptured 1 month after this angiographic study. (D) Emergency CT performed after the patient lost consciousness revealed a massive parenchymal hemorrhage at the left parieto-temporal region. (E and F) Microcatheter was advanced into the ruptured venous aneurysm, where detachable coils were deployed (arrow). (G) Following targeted embolization, the size and flow of the residual AVM were significantly reduced. (H) Follow-up CT 3 months later showed total resolution of the brain edema. (I) The follow-up internal carotid angiogram also demonstrated complete angiographic regression of the residual AVM.

(A) CT angiography (coronal view) revealed a 4-cm AVM at the left temporo-occipital region. (B and C) Lateral projection of early (B) and frontal projection of late (C) arterial phase of left internal carotid angiograms demonstrated a high-flow AVM and a co-existing venous aneurysm on the draining vein (arrow), which ruptured 1 month after this angiographic study. (D) Emergency CT performed after the patient lost consciousness revealed a massive parenchymal hemorrhage at the left parieto-temporal region. (E and F) Microcatheter was advanced into the ruptured venous aneurysm, where detachable coils were deployed (arrow). (G) Following targeted embolization, the size and flow of the residual AVM were significantly reduced. (H) Follow-up CT 3 months later showed total resolution of the brain edema. (I) The follow-up internal carotid angiogram also demonstrated complete angiographic regression of the residual AVM.

DISCUSSION

Spontaneous AVM regression is a rare event [3]. It has been postulated that this phenomenon is closely correlated with various clinical or radiological features. For example, AVM with hemorrhagic presentation has been shown to be related to this phenomenon [2, 3]. Possible causes include ‘mass effects’ or ‘brain swelling’ secondary to parenchymal hemorrhage. Either cause will result in kinking or even occlusion of the vasculature related to the AVM, and these anatomical and hemodynamic disturbances might subsequently lead to nidus obliteration. AVM size and the number of arterial feeders are also important. Previous reports have demonstrated that 93% of AVMs with spontaneous regression are smaller than 2 cm [4], and there are significantly fewer feeding arteries in AVMs that undergo spontaneous regression [3]. AVMs harboring only a single draining vein have also been shown to have a greater chance of undergoing spontaneous regression than those with multiple draining veins [2]. A possible explanation for this is that venous outflow obstruction can lead to flow stasis inside the AVM nidus, and obstruction of a single vein is more likely to occur than obstruction of multiple draining veins [4]. This hypothesis appears somewhat contradictory to the previous observation in that venous outlet restriction is actually a known risk factor for AVM rupture [5]. However, when the restriction process is gradual, and there is a concomitant reduction of AVM flow, the overall hemodynamic changes might favor flow stasis inside the AVM nidus, leading to AVM obliteration. Regarding our case, the original AVM was large, the shunting flow was high, and there were multiple arterial feeders and a single major draining vein. The overall angio-architecture not only did not favor spontaneous regression, but also warranted aggressive treatment. However, after the AVM ruptured, the parenchymal hemorrhage caused significant brain edema and mass effects on the whole AVM complex, including the feeding arteries, nidus and single draining vein. Our embolization procedure further converted this AVM into a malformation of significantly smaller size, fewer arterial feeders and a smaller shunting flow. Therefore, in combining multiple favoring factors, including the patient’s clinical presentation (i.e. hemorrhage and brain edema), pre-existing angio-architectural factors (i.e. a single draining vein), and post-procedural factors (i.e. post-embolization flow reduction), the AVM was converted to a hemodynamic status more susceptible to regression. Over a period of time, the whole AVM complex, including the venous outflow, the remaining arterial feeders and the AVM nidus, gradually underwent thrombosis and regression. Finally, the AVM completely regressed, and additional definite treatment was no longer necessary. This case study may change our perception and broaden our considerations in treatment planning for AVM. Neurosurgical excision and radiosurgery, with or without adjuvant embolization, are the two standard modalities for definite treatment of cerebral AVM. However, when the clinical conditions or radiological characteristics of the AVM preclude the possibility of definite treatment, targeted treatment of the AVM is considered a better option, in order to reduce AVM-related risks [6]. As seen in our case, the initial strategy of definite treatment for the patient was changed to a life-saving strategy after when life-threatening hemorrhage occurred. Although this strategy left a residual AVM behind, it created a less-risky clinical environment that allowed the patient to recover gradually without delay. Furthermore, as most of the factors favoring spontaneous AVM regression were present, we were able to adopt a wait-and-see policy in terms of its possible occurrence without posing additional risks to the patient. We, therefore, hypothesized that rendering the ruptured AVM more susceptible to spontaneous obliteration by targeted embolization of the AVM was an alternative treatment consideration, especially when definite treatment was not possible or not suitable. Of course, angiographic follow-up at regular intervals was mandatory in order to confirm AVM obliteration and to ensure that the AVM did not recanalize [7]. In conclusion, we postulate that, in certain circumstances, when definite treatment for a ruptured AVM is too risky, an alternative strategy is to treat the AVM to result in a hemodynamic status that fulfills as many as possible factors favorable for spontaneous AVM regression.
  7 in total

1.  Spontaneous obliteration of pial arteriovenous malformations: a review of 27 cases.

Authors:  M C Patel; T J Hodgson; A A Kemeny; D M Forster
Journal:  AJNR Am J Neuroradiol       Date:  2001-03       Impact factor: 3.825

2.  Risk of intracranial arteriovenous malformation rupture due to venous drainage impairment. A theoretical analysis.

Authors:  G J Hademenos; T F Massoud
Journal:  Stroke       Date:  1996-06       Impact factor: 7.914

3.  Spontaneous angiographic regression of cerebral arteriovenous malformations: angiographic disappearance is not the real cure.

Authors:  Fumihiro Matano; Yasuo Murai; Shunsuke Nakagawa; Takeshi Wada; Takayuki Kitamura; Akira Teramoto
Journal:  Turk Neurosurg       Date:  2015       Impact factor: 1.003

Review 4.  Spontaneous angiographic obliteration of cerebral arteriovenous malformations.

Authors:  S I Abdulrauf; G M Malik; I A Awad
Journal:  Neurosurgery       Date:  1999-02       Impact factor: 4.654

5.  Spontaneous regression of brain arteriovenous malformations--a clinical study and a systematic review of the literature.

Authors:  Dennis R Buis; René van den Berg; Geert Lycklama; H Bart van der Worp; Clemens M F Dirven; W Peter Vandertop
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

Review 6.  Partial "targeted" embolisation of brain arteriovenous malformations.

Authors:  Timo Krings; Franz-Josef Hans; Sasikhan Geibprasert; Karel Terbrugge
Journal:  Eur Radiol       Date:  2010-06-11       Impact factor: 5.315

7.  Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial.

Authors:  J P Mohr; Michael K Parides; Christian Stapf; Ellen Moquete; Claudia S Moy; Jessica R Overbey; Rustam Al-Shahi Salman; Eric Vicaut; William L Young; Emmanuel Houdart; Charlotte Cordonnier; Marco A Stefani; Andreas Hartmann; Rüdiger von Kummer; Alessandra Biondi; Joachim Berkefeld; Catharina J M Klijn; Kirsty Harkness; Richard Libman; Xavier Barreau; Alan J Moskowitz
Journal:  Lancet       Date:  2013-11-20       Impact factor: 79.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.